Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
20.30M | 85.10M | 86.70M | 87.60M | 79.13M | 65.48M | Gross Profit |
15.80M | 37.70M | 81.60M | 79.10M | 37.63M | 30.25M | EBIT |
-11.50M | 23.50M | 55.50M | 54.10M | 9.26M | 625.00K | EBITDA |
29.10M | -12.50M | 58.30M | 57.70M | 40.50M | 26.58M | Net Income Common Stockholders |
-10.10M | -20.10M | 11.40M | 10.90M | 3.80M | -2.21M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
62.20M | 55.70M | 46.70M | 118.20M | 57.29M | 91.60M | Total Assets |
1.14B | 601.60M | 1.26B | 1.38B | 1.15B | 908.20M | Total Debt |
0.00 | 516.90M | 1.16B | 1.22B | 1.05B | 851.90M | Net Debt |
-62.20M | 463.70M | 1.12B | 1.10B | 987.88M | 760.30M | Total Liabilities |
1.04B | 542.30M | 1.19B | 1.27B | 1.10B | 898.20M | Stockholders Equity |
4.40M | 59.30M | 76.50M | 103.30M | 48.25M | 10.00M |
Cash Flow | Free Cash Flow | ||||
-160.70M | 25.40M | -25.40M | 36.30M | -218.53M | -404.66M | Operating Cash Flow |
-159.60M | 28.60M | -18.90M | 39.70M | -216.12M | -401.11M | Investing Cash Flow |
-11.20M | -16.90M | 11.70M | -191.00M | -2.43M | -3.47M | Financing Cash Flow |
154.40M | -2.70M | -64.30M | 207.30M | 189.10M | 456.11M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | £1.73B | 10.02 | 13.14% | 4.55% | 27.88% | 28.92% | |
77 Outperform | £1.71B | 6.01 | 13.70% | 7.20% | 18.67% | 17.42% | |
68 Neutral | £744.36M | 17.50 | 3.67% | ― | -11.82% | -54.07% | |
64 Neutral | $12.74B | 9.85 | 7.88% | 17015.07% | 12.17% | -6.02% | |
60 Neutral | $500.22M | 4.53 | -6.71% | ― | 3.73% | -172.06% | |
54 Neutral | £41.39M | ― | -16.30% | ― | -10.35% | 18.10% |